What I Wish Everyone Knew About 61-82-5

Welcome to talk about 61-82-5, If you have any questions, you can contact Dogra, S; Kar, AK; Girdhar, K; Daniel, PV; Chatterjee, S; Choubey, A; Ghosh, S; Patnaik, S; Ghosh, D; Mondal, P or send Email.. Quality Control of 1H-1,2,4-Triazol-5-amine

Dogra, S; Kar, AK; Girdhar, K; Daniel, PV; Chatterjee, S; Choubey, A; Ghosh, S; Patnaik, S; Ghosh, D; Mondal, P in [Dogra, Surbhi; Girdhar, Khyati; Daniel, P. Vineeth; Chatterjee, Swarup; Choubey, Abhinav; Ghosh, Subrata; Mondal, Prosenjit] Indian Inst Technol Mandi, Sch Basic Sci, Mandi, Himachal Prades, India; [Kar, Aditya K.; Patnaik, Satyakam; Ghosh, Debabrata] ITTR, CSIR, Lucknow, Uttar Pradesh, India published Zinc oxide nanoparticles attenuate hepatic steatosis development in high-fat-diet fed mice through activated AMPK signaling axis in 2019.0, Cited 29.0. Quality Control of 1H-1,2,4-Triazol-5-amine. The Name is 1H-1,2,4-Triazol-5-amine. Through research, I have a further understanding and discovery of 61-82-5.

Insulin resistance is thought to be a common link between obesity and Non-Alcoholic Fatty Liver Disease (NAFLD). NAFLD has now reached epidemic status worldwide and identification of molecules or pathways as newer therapeutic strategies either to prevent or overcome insulin resistance seems critical. Dysregulated hepatic lipogenesis (DNL) is a hallmark of NAFLD in humans and rodents. Therefore, reducing DNL accretion may be critical in the development of therapeutics of NAFLD. In our in vivo model (high-fat-diet fed [HFD] obese mice) we found Zinc oxide nanoparticles (ZnO NPs) significantly decreased HFD-induced hepatic steatosis and peripheral insulin resistance. This protective mechanism of ZnO NPs was signaled through hepatic SIRT1-LKB1-AMPK which restricted SREBP-lc within the cytosol limiting its transcriptional ability and thereby ameliorating HFD mediated DNL. These observations indicate that ZnO NP can serve as a therapeutic strategy to improve the physiological homeostasis during obesity and its associated metabolic abnormalities. (C) 2019 Elsevier Inc. All rights reserved.

Welcome to talk about 61-82-5, If you have any questions, you can contact Dogra, S; Kar, AK; Girdhar, K; Daniel, PV; Chatterjee, S; Choubey, A; Ghosh, S; Patnaik, S; Ghosh, D; Mondal, P or send Email.. Quality Control of 1H-1,2,4-Triazol-5-amine

Reference:
Article; Safari, Niloufar; Shirini, Farhad; Tajik, Hassan; Journal of Molecular Structure; vol. 1201; (2020);,
1,2,3-Triazole – Wikipedia,
Triazoles – an overview | ScienceDirect Topics